|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Ou Su-Fong | Kenneth Lu | Liu Chun-Chieh | 02-26558000 | 4F., No.3-1, Yuanqu St., Nangang Dist.,Taipei City 115, Taiwan (R.O.C.) | 2004/11/29 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Universal Vision Biotechnology is a professional provider of brand licensing and consulting services to eye clinics in Taiwan, including introduction and leasing of ophthalmic machinery and equipment, procurement of medical supplies and consumables, business location assessment and store design, brand marketing, and other administrative supports. While medical professionals focus on providing quality medical care and service, we help partnered clinics maximize their operational performance. Medical-based optometry and prescription service is also integrated and offered with ophthalmology, creating a one stop shopping vision care solution for customers in need. |
Market Information ( 2024/04/26 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
472.853 | 243.50 | 239.50 | 240.00 | -0.50 | 964 | .00 | 1,794 | 3 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/04/29) |
TPEx measures adopted (2024/04/29) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | Y | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |